Please login to the form below

Not currently logged in
Email:
Password:

Positive opinion for Allergan's NDO treatment

A positive opinion is given from the Irish Medicines Board for BOTOX treatment for neurogenic detrusor overactivity (NDO)

Allergan's BOTOX has received a positive opinion from the Irish Medicines Board, for the use of BOTOX for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO).

NDO results from neurogenic bladder, due to stable sub-cervical spinal cord injury (SCI) or multiple sclerosis (MS). NDO results in involuntary contractions of the detrusor muscle within the bladder during its filling stage. This over activity often leads to urinary incontinence.

It has been shown that targeted injections of BOTOX into the bladder muscle can reduce the involuntary contractions and increase bladder capacity, therefore reducing the number of urinary leaks.

Gaining this opinion is considered to be an important step towards securing national licences in the 14 European countries involved in the Mutual Recognition Procedure.

9th August 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....